Alignment between Duplex Sequencing and transgenic rodent mutation assay data in the assessment of in vivo NDMA-induced mutagenesis
Anthony M Lynch(Age UK), Joanne Elloway(AstraZeneca (United Kingdom)), John W. Wills(Age UK), Kevin C. Vavra, Thomas H. Smith, Jonathan Howe(GlaxoSmithKline (United Kingdom)), Jacob E. Higgins, Daniela Nachmanson, Jesse J. Salk(University of Washington), Farah A. Dahalan(AstraZeneca (South Korea)), Ann Doherty(AstraZeneca (South Korea))
Cited by 8
Related Papers
Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2010|106
The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
|Journal of Clinical Gastroenterology|2012|92
Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters
|Mutagenesis|2023|56
Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip
|Cell stem cell|2024|29